Retinoid X receptors: X-ploring their (patho)physiological functions

A Szanto1, V Narkar, Q Shen

  • 1Department of Biochemistry and Molecular Biology, Research Center for Molecular Medicine, University of Debrecen, Nagyerdei krt. 98, Debrecen H-4012, Hungary.

Insights

Retinoid X receptor (RXR) is a key transcription factor regulating diverse biological pathways. This review explores RXR's evolution, structure, ligands, and roles in development and disease, highlighting its therapeutic potential.

Area of Science:

  • Molecular Biology
  • Genetics
  • Endocrinology

Background:

  • Retinoid X receptor (RXR) is a ligand-activated transcription factor crucial for metazoan life.
  • RXR acts as a heterodimerization partner for various nuclear receptors, positioning it at the convergence of multiple biological pathways.
  • The precise endogenous ligand requirements for RXR function remain an area of active investigation, contributing to its enigmatic nature.

Purpose of the Study:

  • To provide a comprehensive review of Retinoid X receptor (RXR) biology.
  • To elucidate RXR's evolutionary context, structural characteristics, and ligand interactions.
  • To discuss RXR's regulatory roles in development, metabolism, myeloid differentiation, and apoptosis, and assess its therapeutic potential.

Main Methods:

  • Literature review synthesizing existing research on RXR.
  • Analysis of data from knockout animal studies to understand developmental roles.
  • Examination of pharmacological studies investigating RXR's metabolic functions in disease models.

Main Results:

  • RXR plays critical roles in embryonic development, as evidenced by knockout studies.
  • Pharmacological studies demonstrate RXR's involvement in metabolic diseases like diabetes and atherosclerosis.
  • RXR influences myeloid differentiation and apoptosis, with implications for cancer therapy.

Conclusions:

  • RXR is a central regulator of diverse biological processes, from development to disease.
  • Understanding RXR's complex biology and ligand interactions is essential for therapeutic applications.
  • RXR presents a promising, albeit complex, target for pharmacological intervention in various diseases.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: